Trained immunity: A new avenue for tuberculosis vaccine development

45Citations
Citations of this article
172Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Adaptive immunity towards tuberculosis (TB) has been extensively studied for many years. In addition, in recent years the profound contribution of innate immunity to host defence against this disease has become evident. The discovery of pattern recognition receptors, which allow innate immunity to tailor its response to different infectious agents, has challenged the view that this arm of immunity is nonspecific. Evidence is now accumulating that innate immunity can remember a previous exposure to a microorganism and respond differently during a second exposure. Although the specificity and memory of innate immunity cannot compete with the highly sophisticated adaptive immune response, its contribution to host defence against infection and to vaccine-induced immunity should not be underestimated and needs to be explored. Here, we present the concept of trained immunity and discuss how this may contribute to new avenues for control of TB.

Cite

CITATION STYLE

APA

Lerm, M., & Netea, M. G. (2016, April 1). Trained immunity: A new avenue for tuberculosis vaccine development. Journal of Internal Medicine. Blackwell Publishing Ltd. https://doi.org/10.1111/joim.12449

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free